Vance Street Capital Expands Medical Device Portfolio with Injectech Acquisition
In a significant move within the medical manufacturing sector, Vance Street Capital, a respected private equity firm, has announced the acquisition of Injectech from The West Group (TWG). This strategic acquisition expands the offerings of the VSC Medical Molding platform, particularly in the domain of single-use fluid management solutions, which serve the medical device, life science, and bioprocessing markets.
The VSC Medical Molding platform now integrates resources from Injectech, alongside previous acquisitions of Plastic Design Company (PDC) in 2021 and Resenex in 2024, strengthening its footprint in precision molding and fluid management. This acquisition marks Vance Street's third venture in the medical and life science manufacturing space in 2025, following their investments in Zenith Adhesive Component (ZAC) and MRPC.
Jeff Kyle, CEO of VSC Medical Molding, expressed his enthusiasm about the new addition to the team: "We are delighted to welcome Injectech to the VSC Medical Molding family. This acquisition allows us to effectively combine our precision molding capabilities with Injectech’s extensive offerings in custom and standard fluid management solutions, enabling us to deliver tailored solutions for our clients in critical areas of medicine and bioprocessing."
With the integration of Injectech and Resenex, the fluid management division of VSC Medical Molding is set to provide a broader array of products and enhanced custom component capabilities. The unification of these companies aims to address an expanded range of fluid management requirements, focusing specifically on serving the vital sectors of medical devices and life sciences.
Jeff Wicks, CEO of Injectech, is optimistic about the growth trajectory this merger represents, stating, "We are excited about this new chapter of growth and our partnership with VSC Medical Molding and Vance Street. This combination will not only accelerate our growth but also drive product innovation, allowing us to better meet the evolving needs of our customers."
Steve Sandbo, Partner at Vance Street Capital, added, "The addition of Injectech to our portfolio brings deep expertise in precision fluid management along with a strong culture of innovation. Together, we will continue to build a leading platform in precision molding and fluid management that caters to the medical device and life science industries."
Founded in 1998 and headquartered in Fort Collins, Colorado, Injectech has earned a reputation as a trusted partner for medical device OEMs, life science innovators, and bioprocess manufacturers worldwide. Their specialization lies in high-precision injection molding and clean-room assembly, making them an ideal complement to the existing capabilities of VSC Medical Molding.
Additionally, the partners at VSC are excited about integrating the expertise and advanced technologies developed by Plastic Design Company and Resenex into Injectech’s operations. For instance, PDC has been recognized throughout its 30-year history for its pioneering work with complex materials and custom manufacturing for the medical device and life science markets.
With this acquisition, Vance Street not only enhances its market reach but also reinforces its commitment to delivering high-quality solutions, ensuring that each component manufactured meets stringent industry standards. The collaboration among VSC Medical Molding, Injectech, PDC, and Resenex reflects a shared vision of innovation and excellence, aimed at driving advancements in patient care and life sciences.
For those interested in further information about Injectech and their products, additional details can be found at their official website. Through these continued efforts and strategic alignments, Vance Street Capital is ideally positioned to lead in the competitive landscape of medical device manufacturing.
The VSC Medical Molding platform now integrates resources from Injectech, alongside previous acquisitions of Plastic Design Company (PDC) in 2021 and Resenex in 2024, strengthening its footprint in precision molding and fluid management. This acquisition marks Vance Street's third venture in the medical and life science manufacturing space in 2025, following their investments in Zenith Adhesive Component (ZAC) and MRPC.
Jeff Kyle, CEO of VSC Medical Molding, expressed his enthusiasm about the new addition to the team: "We are delighted to welcome Injectech to the VSC Medical Molding family. This acquisition allows us to effectively combine our precision molding capabilities with Injectech’s extensive offerings in custom and standard fluid management solutions, enabling us to deliver tailored solutions for our clients in critical areas of medicine and bioprocessing."
With the integration of Injectech and Resenex, the fluid management division of VSC Medical Molding is set to provide a broader array of products and enhanced custom component capabilities. The unification of these companies aims to address an expanded range of fluid management requirements, focusing specifically on serving the vital sectors of medical devices and life sciences.
Jeff Wicks, CEO of Injectech, is optimistic about the growth trajectory this merger represents, stating, "We are excited about this new chapter of growth and our partnership with VSC Medical Molding and Vance Street. This combination will not only accelerate our growth but also drive product innovation, allowing us to better meet the evolving needs of our customers."
Steve Sandbo, Partner at Vance Street Capital, added, "The addition of Injectech to our portfolio brings deep expertise in precision fluid management along with a strong culture of innovation. Together, we will continue to build a leading platform in precision molding and fluid management that caters to the medical device and life science industries."
Founded in 1998 and headquartered in Fort Collins, Colorado, Injectech has earned a reputation as a trusted partner for medical device OEMs, life science innovators, and bioprocess manufacturers worldwide. Their specialization lies in high-precision injection molding and clean-room assembly, making them an ideal complement to the existing capabilities of VSC Medical Molding.
Additionally, the partners at VSC are excited about integrating the expertise and advanced technologies developed by Plastic Design Company and Resenex into Injectech’s operations. For instance, PDC has been recognized throughout its 30-year history for its pioneering work with complex materials and custom manufacturing for the medical device and life science markets.
With this acquisition, Vance Street not only enhances its market reach but also reinforces its commitment to delivering high-quality solutions, ensuring that each component manufactured meets stringent industry standards. The collaboration among VSC Medical Molding, Injectech, PDC, and Resenex reflects a shared vision of innovation and excellence, aimed at driving advancements in patient care and life sciences.
For those interested in further information about Injectech and their products, additional details can be found at their official website. Through these continued efforts and strategic alignments, Vance Street Capital is ideally positioned to lead in the competitive landscape of medical device manufacturing.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.